TREAT PTSD VA Act
- Bill Number
- H.R. 8763
- Origin Chamber
- House
- Congress
- 119th Congress, Session 2
- Status
- Introduced
- Latest Action
- 2026-05-12: Referred to the House Committee on Veterans' Affairs.
- Last Updated
- 2026-05-15T05:23:25Z
AI-Generated Summary
Summary of H.R. 8763 (TREAT PTSD VA Act)
Purpose
The legislation directs the Department of Veterans Affairs (VA) to provide stellate ganglion block—a medical procedure involving an injection near nerves in the neck—as a treatment option for veterans diagnosed with post-traumatic stress disorder (PTSD). It aims to expand access to this emerging therapy for eligible veterans enrolled in the VA health care system.
Key Provisions
- Mandatory Provision of Treatment: The bill adds a new section (1720M) to title 38 of the U.S. Code, requiring the VA Secretary to furnish stellate ganglion block to veterans who meet these criteria:
- Enrollment in the VA patient enrollment system.
- Diagnosis of PTSD.
- Election to receive the treatment after being informed by a qualified health care provider about its risks and benefits.
- Delivery Options: The VA may provide the treatment at its own medical facilities or through approved non-VA providers under existing community care rules.
- Guideline Update: Within 180 days of enactment, the VA must update the VA/DOD Clinical Practice Guideline for the Management of PTSD to include stellate ganglion block as a therapy option, along with details on its clinical indicators and contraindications (situations where it should not be used).
- Notification Requirement: The VA must inform the House and Senate Committees on Veterans' Affairs once the guideline update is complete.
- Effective Date: The new treatment requirement takes effect 180 days after the bill becomes law.
Significant Changes to Existing Law
This bill introduces a new mandatory service under VA health care law by adding section 1720M to chapter 17 of title 38, U.S. Code. It does not repeal or modify prior statutes but expands the range of covered treatments for PTSD beyond current standards, requiring the VA to make this specific procedure available upon veteran request.
Potential Impacts
- On Government Agencies: The VA would need to train providers, allocate resources, and integrate the procedure into its care delivery system, potentially increasing administrative and medical costs. It must also revise official clinical guidelines within a set timeframe.
- On Citizens: Eligible veterans with PTSD could gain earlier access to this therapy option, which may offer relief where standard treatments fall short, though availability depends on informed consent and medical suitability.
- On International Relations: No direct effects are outlined in the bill.
Main Stakeholders Affected
- Veterans enrolled in VA care who have been diagnosed with PTSD.
- The Department of Veterans Affairs and its health care providers.
- Congressional committees overseeing veterans' affairs.
Notable Legal, Constitutional, or Political Implications
The bill establishes a legal mandate for a specific medical intervention, which could raise questions about the balance between congressional direction of agency practices and professional medical judgment. It has no apparent constitutional issues but may influence future policy debates on veterans' mental health care access and the integration of emerging treatments into federal guidelines.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Recent Actions
- 2026-05-12: Referred to the House Committee on Veterans' Affairs.
- 2026-05-12: Introduced in House
- 2026-05-12: Introduced in House
Bill Versions
- Treatment and Relief through Emerging and Accessible Therapy for PTSD VA Act — issued 2026-05-12 — PDF (3 pages)